Literature DB >> 22844356

Expression of K19 and K7 in dysplastic nodules and hepatocellular carcinoma.

Jun Sang Bae1, Ha Na Choi, Sang Jae Noh, Byung Hyun Park, Kyu Yun Jang, Cheol Keun Park, Woo Sung Moon.   

Abstract

Hepatocellular carcinoma (HCC) is one of the most common types of malignant tumors characterized by a multistep process of tumor development. Nodular lesions that differ from the surrounding liver parenchyma and are characterized by cytological or structural atypia are termed dysplastic nodules (DNs). DNs are well-known precancerous HCC lesions. Expression of keratin (K) 19 and K7, molecular markers of hepatic progenitor cells and cholangiocytes, has been reported in certain HCCs. However, it remains unclear whether K19-positive HCC cells are derived from true hepatic progenitor cells or mature cells that have undergone a dedifferentiation or a transdifferentiation process. In total, 107 tissue sections (13 low-grade DNs, 15 high-grade DNs, 27 small HCCs and 52 large HCCs) from resected liver samples and 132 HCC tissue microarray (TMA) cores were subjected to immunohistochemical analysis for K19 and K7. Clinicopathological data of the HCC patients were evaluated. K19 expression was found in 0% of DNs, 19% of small HCCs (≤2 cm), 8% of large HCCs (>2 cm) and 8% of TMA samples. K7 expression was found in 14% of DNs, 41% of small HCCs, 15% of large HCCs and 6% of TMA samples. Among the five K19-positive small HCCs, four were distinctly nodular and one tumor was an infiltrative type. No vaguely nodular HCC was positive for K19. K19 expression was significantly associated with histological grade (P=0.023), serum α-fetoprotein level (P=0.001) and K7 expression (P=0.001) in HCC. K19 expression was an independent prognostic factor for overall survival in non-viral HCC patients (P=0.003). K19 expression is extremely rare in DNs and occurs in progressed small HCCs. Our results suggest that K19 expression may be an acquired feature of carcinoma cells during HCC progression in certain HCCs.

Entities:  

Year:  2012        PMID: 22844356      PMCID: PMC3402733          DOI: 10.3892/ol.2012.731

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  29 in total

1.  Mixed phenotype hepatocellular carcinoma after transarterial chemoembolization and liver transplantation.

Authors:  Chikako Zen; Yoh Zen; Ragai R Mitry; Denis Corbeil; Jana Karbanová; John O'Grady; John Karani; Pauline Kane; Nigel Heaton; Bernard C Portmann; Alberto Quaglia
Journal:  Liver Transpl       Date:  2011-08       Impact factor: 5.799

2.  Biliary phenotype of hepatocellular carcinoma after preoperative transcatheter arterial chemoembolization.

Authors:  Yunosuke Nishihara; Shinichi Aishima; Yousuke Kuroda; Tomohiro Iguchi; Kenichi Taguchi; Yoshiki Asayama; Akinobu Taketomi; Naoko Kinukawa; Hiroshi Honda; Masazumi Tsuneyoshi
Journal:  J Gastroenterol Hepatol       Date:  2008-09-24       Impact factor: 4.029

3.  The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin.

Authors:  A Durnez; C Verslype; F Nevens; J Fevery; R Aerts; J Pirenne; E Lesaffre; L Libbrecht; V Desmet; T Roskams
Journal:  Histopathology       Date:  2006-08       Impact factor: 5.087

Review 4.  Tissue microarrays for miniaturized high-throughput molecular profiling of tumors.

Authors:  Ronald Simon; Guido Sauter
Journal:  Exp Hematol       Date:  2002-12       Impact factor: 3.084

5.  Expression of keratin 19 is related to high recurrence of hepatocellular carcinoma after radiofrequency ablation.

Authors:  Kaoru Tsuchiya; Mina Komuta; Yutaka Yasui; Nobuharu Tamaki; Takanori Hosokawa; Ken Ueda; Teiji Kuzuya; Jun Itakura; Hiroyuki Nakanishi; Yuka Takahashi; Masayuki Kurosaki; Yasuhiro Asahina; Nobuyuki Enomoto; Michiie Sakamoto; Namiki Izumi
Journal:  Oncology       Date:  2011-07-07       Impact factor: 2.935

6.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

7.  Hepatocellular carcinoma expressing cholangiocyte phenotype is a novel subtype with highly aggressive behavior.

Authors:  Xin-Yuan Lu; Tao Xi; Wan-Yee Lau; Hui Dong; Zhen Zhu; Feng Shen; Meng-Chao Wu; Wen-Ming Cong
Journal:  Ann Surg Oncol       Date:  2011-02-10       Impact factor: 5.344

Review 8.  Understanding the cancer stem cell.

Authors:  S Bomken; K Fiser; O Heidenreich; J Vormoor
Journal:  Br J Cancer       Date:  2010-07-27       Impact factor: 7.640

9.  Heterogeneity in cancer: cancer stem cells versus clonal evolution.

Authors:  Mark Shackleton; Elsa Quintana; Eric R Fearon; Sean J Morrison
Journal:  Cell       Date:  2009-09-04       Impact factor: 41.582

10.  Mechanisms of hepatocyte growth factor-mediated and epidermal growth factor-mediated signaling in transdifferentiation of rat hepatocytes to biliary epithelium.

Authors:  Pallavi B Limaye; William C Bowen; Anne V Orr; Jianhua Luo; George C Tseng; George K Michalopoulos
Journal:  Hepatology       Date:  2008-05       Impact factor: 17.425

View more
  2 in total

Review 1.  Identification of New Players in Hepatocarcinogenesis: Limits and Opportunities of Using Tissue Microarray (TMA).

Authors:  Luca Quagliata; Manuel Schlageter; Cristina Quintavalle; Luigi Tornillo; Luigi M Terracciano
Journal:  Microarrays (Basel)       Date:  2014-04-15

Review 2.  The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy.

Authors:  Yanhong Xiao; Mei Lin; Xingmao Jiang; Jun Ye; Ting Guo; Yujuan Shi; Xuefeng Bian
Journal:  Anal Cell Pathol (Amst)       Date:  2017-07-27       Impact factor: 2.916

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.